AGF Investments LLC’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-495
Closed -$178K 534
2021
Q4
$178K Sell
495
-90
-15% -$30.4K 0.02% 299
2021
Q3
$190K Sell
585
-32
-5% -$10.8K 0.02% 294
2021
Q2
$193K Buy
617
+312
+102% +$95.7K 0.02% 298
2021
Q1
$97K Sell
305
-126
-29% -$40.3K 0.01% 312
2020
Q4
$140K Buy
431
+357
+482% +$98.7K 0.02% 297
2020
Q3
$21K Buy
+74
New +$21.3K ﹤0.01% 437
2019
Q2
Sell
-1,086
Closed -$310K 710
2019
Q1
$310K Sell
1,086
-5,745
-84% -$1.91M 0.07% 157
2018
Q4
$2.22M Sell
6,831
-537
-7% -$187K 0.31% 77
2018
Q3
$3.31M Sell
7,368
-177
-2% -$69.8K 0.42% 62
2018
Q2
$3.09K Buy
7,545
+4,597
+156% +$1.67M 0.35% 67
2018
Q1
$860K Buy
2,948
+2,840
+2,630% +$720K 0.14% 135
2017
Q4
$21K Buy
+108
New +$20.2K ﹤0.01% 415
2017
Q3
Sell
-72
Closed -$10K 819
2017
Q2
$10K Sell
72
-6
-8% -$806 ﹤0.01% 561
2017
Q1
$10K Sell
78
-10
-11% -$1.16K ﹤0.01% 575
2016
Q4
$10K Buy
+88
New +$10.2K ﹤0.01% 654

Other funds holding ABMD

AGF Investments LLC's ABMD Position: Q1 2022 in Review

AGF Investments LLC sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 495 shares — an estimated $178K sold.

AGF Investments LLC first reported a position in ABMD in Q4 2016 and held it in 15 quarters. The position peaked at $3.31M in Q3 2018. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • AGF Investments LLC reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • AGF Investments LLC sold 495 Abiomed Inc shares in Q1 2022, an estimated $178K.
  • AGF Investments LLC first reported a position in Abiomed Inc in Q4 2016 and held it in 15 quarters.
  • AGF Investments LLC's Abiomed Inc position peaked at $3.31M in Q3 2018.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on AGF Investments LLC's 13F filing for Q1 2022, filed 10 May 2022.